Mesothelioma Research

Considerable progress has been made in the field of mesothelioma research and clinical trials in recent years.


Although there is still no method for early detection of mesothelioma, there have been advances in technology. It is important for anyone who has knowingly been exposed to asbestos to tell their physician, who may suggest he or she have these tests performed:

  • Chest x-ray detects abnormalities within the chest.
  • Magnetic resonance imaging (MRI) scan helps to determine if an abnormality in the chest is mesothelioma or a non-malignant tumor.
  • Computer Tomography (CT) scans can create detailed images of the chest and show any abnormalities.

Clinical Trials

Clinical trials are crucial to the field of mesothelioma treatment research, as they not only shed light upon the illness, they also give patients suffering from this debilitating illness hope. If you or a loved one is suffering from mesothelioma, more information regarding clinical studies and how to participate in them is available upon request, and can be a critical tool in improving the quality of life of those affected.

In recent months, a new drug called Alimta (Pemetrexed) has shown great success in clinical studies. When used in conjunction with Cisplatin, a chemotherapy drug that interferes with cancer cell growth, Alimta is intended to stop cancer cell multiplication entirely. Alimta has just recently been approved by the FDA for mesothelioma patients, particularly in patients who do not have the option of surgically removing the cancerous cells. While it is important to remember that this drug is new and there are few records to prove its effectiveness, there have been reports of a 54-year old patient in Africa who participated in the Alimta study and returned to work after five treatments; a testimony to the importance of clinical research and studies.

Interesting and positive research work is also being done at the Josson Cancer Center. A drug, Tarceva, is being combined with anti-inflammatory drug, Celebrex, and is reportedly showing an three time increased response rate in cancer patients. Again, these are only initial findings and need to be validated before this treatment can be approved as safe and effective.

First Name:
Last Name:
Have you or someone you know been diagnosed with Mesothelioma?
Yes No
Thank you for visiting this website which is created for the benefit of the general public. This website and its content are produced and sponsored by the law firm of James F. Early, LLC (James F. Early, Esq.). All of the information is intended as a resource available at no cost to people diagnosed with mesothelioma and their loved ones. Nonetheless, it may be considered attorney advertising. The content contained herein was not prepared by medical professionals and it is not intended, nor should it be considered, as a substitute for medical advice. The information provided on this website is intended as educational material, designed solely to support, and not replace, the relationship that exists between a patient/site visitor and his/her healthcare professional. Additionally, neither visiting this website nor viewing its content is intended, and shall not be considered, to create an attorney-client relationship. An attorney-client relationship can only be created by mutual agreement and consent of the prospective client and the attorney. Neither the transmission nor receipt of this website material creates an attorney-client relationship between sender and receiver. The material contained herein is general in nature and may not apply to your particular factual or legal circumstances. Online readers should not act on this information without seeking professional counsel and advice. All information on this website is provided as a resource for the convenience and benefit of visitors to this website and their families. No affiliation with or endorsement of: (1) this website by the persons, facilities or organizations listed herein; OR (2) such persons, facilities or organizations by this website, is intended, nor should it be inferred. In all cases and without exception, such visitors and their families, for their own particular situation, must perform their own investigation of the suitability and appropriateness of any such person, facility or organization. Please read our disclaimer for more information.